Anne ORiordan, Director at Jazz Pharmaceuticals plc (JAZZ), sold 923 shares at $148.92 ($137K) on 2022-05-09, disclosed to the SEC on 2022-05-11.
Open-market sale of $137k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $148.92 | 457 | $68K | 49.5% |
| 2 | $148.92 | 457 | $68K | 49.5% |
| 3 | $150.49 | 9 | $1K | 1.0% |
| Total | $148.93 avg | 923 | $137K | 100% |
| Filing → |